SERTAD1 and neoplasm: qPCR analysis of the tumor tissue demonstrated that the expressions of DNA damage marker genes (TP53BP1, PARP1, and BRCA1), cGAS, STING, SEI1, and PD‐L1 were increased in melphalan or bortezomib treated mice (Figure 6A,B).